Your browser doesn't support javascript.
loading
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment.
Wang, Yufeng; Drum, David L; Sun, Ruochuan; Zhang, Yida; Chen, Feng; Sun, Fengfei; Dal, Emre; Yu, Ling; Jia, Jingyu; Arya, Shahrzad; Jia, Lin; Fan, Song; Isakoff, Steven J; Kehlmann, Allison M; Dotti, Gianpietro; Liu, Fubao; Zheng, Hui; Ferrone, Cristina R; Taghian, Alphonse G; DeLeo, Albert B; Ventin, Marco; Cattaneo, Giulia; Li, Yongxiang; Jounaidi, Youssef; Huang, Peigen; Maccalli, Cristina; Zhang, Hanyu; Wang, Cheng; Yang, Jibing; Boland, Genevieve M; Sadreyev, Ruslan I; Wong, LaiPing; Ferrone, Soldano; Wang, Xinhui.
Affiliation
  • Wang Y; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Drum DL; Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Sun R; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhang Y; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Chen F; Department of Gastrointestinal Surgery and General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Sun F; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Dal E; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Yu L; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Jia J; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Arya S; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Jia L; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Fan S; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Isakoff SJ; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Kehlmann AM; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Dotti G; Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Liu F; Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Zheng H; Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
  • Ferrone CR; Department of Hepatobiliary & Pancreatic Surgery and Liver Transplantation, Anhui Medical University, Hefei, Anhui, China.
  • Taghian AG; Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • DeLeo AB; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Ventin M; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Cattaneo G; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Li Y; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Jounaidi Y; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Huang P; Department of Gastrointestinal Surgery and General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Maccalli C; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhang H; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wang C; Research Department, Sidra Medicine, Doha, Qatar.
  • Yang J; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Boland GM; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Sadreyev RI; Center for Comparative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wong L; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ferrone S; Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wang X; Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Nat Commun ; 14(1): 5727, 2023 09 15.
Article in En | MEDLINE | ID: mdl-37714830
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Chimeric Antigen Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Chimeric Antigen Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: Estados Unidos